"Gilad" announced that it had received a license to use the drug, which is sold under the name "Viclor," explaining that remdesivir is the only special treatment for Covid-19 that has so far obtained a full license after a more stringent and final audit, according to Al-Arabiya.
Gilead ayaa ku dhawaaqday inay heshay rukhsad ay ku isticmaasho daawada, taas oo lagu iibin doono magaca "Veklury," iyadoo sii sharraxaysa ayaa tiri in Remdesivir ay tahay daweynta keliya ee gaarka u ah Covid-19, oo ilaa hadda heshay liisan buuxa ka dib markii ay mareen dariiq adag oo baaritaan adag oo kama dambeys ahaa.